Stock Screener App

Gratuito -

Installare

Diagnostics & Research

102.24

0.31% 0.27

Revvity Inc (RVTY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RVTY Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Revvity Inc Borsa (RVTY) Ultime notizie

What drives Revvity Inc. stock priceMarket-beating performance - PrintWeekIndia

Revvity Inc. Stock Analysis and ForecastHigh-impact investment strategies - Autocar Professional

Revvity's Consistent Dividend Payout in a High-Growth Sector: A Strategic Indicator for Long-Term Investors - AInvest

Revvity Board Declares Quarterly Dividend - Business Wire

Revvity Q2 Preview: Can Strong Segments Deliver an Earnings Beat? - Yahoo Finance

What analysts say about Revvity Inc. stockUnprecedented market success - Autocar Professional

Is Revvity Inc. a good long term investmentStrong return on investment - Autocar Professional

Wall Street's Insights Into Key Metrics Ahead of Revvity (RVTY) Q2 Earnings - Yahoo Finance

Investors Interested In Revvity, Inc.'s (NYSE:RVTY) Earnings - simplywall.st

Revvity (RVTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance

Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - FinancialContent

How the (RVTY) price action is used to our Advantage - news.stocktradersdaily.com

Earnings Preview: What to Expect From Revvity's Report - MSN

YieldBoost Revvity To 8.9% Using Options - Nasdaq

Ex-Dividend Reminder: Williams Sonoma, Revvity and Zoetis - Nasdaq

Revvity, Inc. Q2 2025 Earnings Preview: Market Expectations and PredictionsNews and Statistics - IndexBox

Revvity Dividend and Company Updates: Key Insights Before Jul 18, 2025 - AInvest

Revvity Inc. Stock Slides 3.0%, Underperforms Market - 富途牛牛

Earnings Preview: What To Expect From Revvity's Report - Barchart.com

Reflecting On Research Tools & Consumables Stocks’ Q1 Earnings: Revvity (NYSE:RVTY) - Yahoo Finance

Revvity (RVTY) Shares Soar 1.98% on Clinical Trial Success - AInvest

Evercore ISI Adjusts Price Target on Revvity to $115 From $116, Maintains Outperform Rating - MarketScreener

(RVTY) Trading Advice - news.stocktradersdaily.com

Revvity to Hold Earnings Call on Monday, July 28, 2025 - Business Wire

Should You Investigate Revvity, Inc. (NYSE:RVTY) At US$101? - simplywall.st

5 Insightful Analyst Questions From Revvity’s Q1 Earnings Call - Yahoo Finance

What 9 Analyst Ratings Have To Say About Revvity - Benzinga

Barclays Keeps Their Buy Rating on Revvity (RVTY) - The Globe and Mail

Is Revvity Stock Underperforming the Dow? - MSN

Is Revvity Stock Underperforming the Dow? A Case for Undervaluation and Growth - AInvest

Leerink Partners Adjusts Price Target on Revvity to $130 From $135, Maintains Outperform Rating - MarketScreener

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 39% Undervalued - Yahoo Finance

Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch

WAT

$296.56

0.46%

DGX

$170.49

0.94%

NTRA

$142.00

0.46%

LH

$266.95

0.22%

MTD

$1,252.37

0.79%

A

$119.56

0.51%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters